A clinical appraisal of pentapyrrolidinium (M&B 2050) in hypertensive patients.
D001337:Autonomic Agents / Q000627:therapeutic use*; D002317:Cardiovascular Agents; D006973:Hypertension / Q000628:therapy*; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use*
D001337:Autonomic Agents; D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D011758:Pyrroles
AUTONOMIC DRUGS/therapeutic use; HYPERTENSION/therapy; MUSCLE RELAXANTS/therapeutic use; PYRROLES/therapeutic use